Form4insider filings, from the source

SEC Form 4 · accession 0000904454-15-000675

Sagent Pharmaceuticals, Inc. · SGNT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Nov 2, 2015
Accepted (ET)
Nov 4, 2015 · 6:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369786

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F3Nov 2, 2015S80,015$16.8695D3,496,951ISee footnote
Common StockF1,F4Nov 2, 2015S939$16.8695D41,041ISee footnote
Common StockF2,F5Nov 3, 2015S57,565$16.32D3,439,386ISee footnote
Common StockF2,F6Nov 3, 2015S675$16.32D40,366ISee footnote
Common StockF7Nov 4, 2015S458,601$15.45D2,980,785ISee footnote
Common StockF8Nov 4, 2015S5,382$15.45D34,984ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses